Related Experiment Videos
Mitochondrial BAX Determines the Predisposition to Apoptosis in Human AML
Frank Reichenbach1,2,3, Cornelius Wiedenmann1, Enrico Schalk4
1Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany.
Summary
Cell-to-cell variability in apoptosis signaling impacts acute myeloid leukemia (AML) treatment response. Bax protein localization in mitochondria predicts AML patient prognosis and apoptosis susceptibility.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Cell-to-cell variability in apoptosis signaling leads to heterogeneous responses to cytotoxic stress in cancers like acute myeloid leukemia (AML).
- The BCL-2 proteins BAX and BAK are key regulators of apoptosis, with their subcellular localization influencing cellular predisposition to programmed cell death.
- Mitochondrial localization of BAX and BAK is critical for initiating apoptosis, while their translocation to the cytosol inhibits this process.
Purpose of the Study:
- To investigate the role of relative BAX and BAK subcellular localization in determining AML cell apoptosis predisposition.
- To assess the correlation between BAX localization and clinical parameters, including patient survival and disease progression, in AML.
- To evaluate the potential of BAX localization as a predictive biomarker for identifying AML patients who may benefit from cytotoxic therapy.
Main Methods:
- Fractionation of acute myeloid leukemia (AML) cell lines and patient samples to determine the relative subcellular localization of BAX and BAK.
- Analysis of a test cohort (48 AML patients) and a validation cohort (80 elderly AML patients) treated with myelosuppressive chemotherapy.
- Statistical correlation analysis between BAX localization and clinical outcomes such as patient survival, disease progression, FLT3-ITD status, and leukocytosis.
Main Results:
- Relative BAX localization was found to determine the predisposition of AML cell lines to apoptosis.
- Human AML samples exhibited significant variability in relative BAX localization.
- Mitochondria-shifted BAX in a test cohort correlated with improved patient survival, FLT3-ITD status, and leukocytosis.
- In a validation cohort, relative BAX localization correlated with disease progression probability, FLT3-ITD status, and leukocytosis.
Conclusions:
- Relative BAX localization serves as a potential prognostic biomarker in AML, predicting patient outcomes.
- Bax localization reflects cellular predisposition to apoptosis, integrating various contributing factors into a unified pathway.
- Identifying BAX localization patterns may aid in selecting elderly or frail AML patients for effective cytotoxic therapy.